180 Life Sciences Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US68236V2034
USD
2.92
-0.06 (-2.01%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sonoma Pharmaceuticals, Inc.
Plus Therapeutics, Inc.
180 Life Sciences Corp.
Palisade Bio, Inc.
ABVC BioPharma, Inc.
Tempest Therapeutics, Inc.
Synaptogenix, Inc.
Aptorum Group Ltd.
Petros Pharmaceuticals, Inc.
Panbela Therapeutics, Inc.
Universe Pharmaceuticals, Inc.

Why is 180 Life Sciences Corp. ?

1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Net Sales has grown by an annual rate of -1.00% and Operating profit at -329.35% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -6.60
2
The company has declared negative results in Mar'2025 after 5 consecutive positive quarters
  • INTEREST(HY) At USD 0.32 MM has Grown at 1,372.17%
  • OPERATING CASH FLOW(Y) Lowest at USD -19.36 MM
  • OPERATING PROFIT(Q) Lowest at USD -220.49 MM
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -73.74%, its profits have risen by 71%
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -73.74% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is 180 Life Sciences Corp. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
180 Life Sciences Corp.
-72.71%
0.09
916.40%
S&P 500
14.9%
0.77
19.29%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-1.00%
EBIT Growth (5y)
-329.35%
EBIT to Interest (avg)
-6.60
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.46
Sales to Capital Employed (avg)
0.01
Tax Ratio
4.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
24.15%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.13
EV to EBIT
-0.21
EV to EBITDA
-0.21
EV to Capital Employed
0.11
EV to Sales
11.54
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-52.20%
ROE (Latest)
-50.58%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company
ROCE(HY)

Highest at -96.7%

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

NET SALES(9M)

Higher at USD 4.11 MM

CASH AND EQV(HY)

Highest at USD 561.12 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 107.09 times

-27What is not working for the Company
INTEREST(HY)

At USD 0.32 MM has Grown at 1,372.17%

OPERATING CASH FLOW(Y)

Lowest at USD -19.36 MM

OPERATING PROFIT(Q)

Lowest at USD -220.49 MM

PRE-TAX PROFIT(Q)

Lowest at USD -219.87 MM

NET PROFIT(Q)

Lowest at USD -219.87 MM

Here's what is working for 180 Life Sciences Corp.

Net Sales
At USD 4.11 MM has Grown at inf%
Year on Year (YoY)
MOJO Watch
Sales trend is very positive

Net Sales (USD MM)

Cash and Eqv
Highest at USD 561.12 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio
Highest at 107.09 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Sales
Higher at USD 4.11 MM
than preceding 12 month period ended Sep 2025
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

Net Sales (USD MM)

Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for 180 Life Sciences Corp.

Interest
At USD 0.32 MM has Grown at 1,372.17%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Pre-Tax Profit
At USD -219.87 MM has Fallen at -41,378.32%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -219.87 MM has Fallen at -41,378.32%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Cash Flow
Lowest at USD -19.36 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Operating Profit
Lowest at USD -220.49 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit
Lowest at USD -219.87 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -219.87 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)